Immunization

New legislation authorizes licensed New York pharmacists to administer a vaccine for coronavirus disease 2019 (COVID-19) when it becomes available.

The CDC released an updated vaccination guidance on administering routine vaccinations amid the coronavirus disease 2019 (COVID-19) pandemic.

Pharmacies are preparing for what is expected to be a surge in flu vaccinations this year as Americans are putting a greater focus on staying healthy amid the coronavirus pandemic.

Though the COVID-19 pandemic has created intense need for treatment, rapid development of a vaccine could come at a cost.

“As pharmacists, we must continue to recommend vaccinations to all our patients.”

Pharmacies and pharmacists can help the rapid deployment of COVID-19 vaccines when available, NACDS said. 

AstraZeneca has received funds exceeding $1 billion from the US Biomedical Advanced Research and Development Authority (BARDA) for the development, production, and delivery of the University of Oxford’s coronavirus disease 2019 (COVID-19) vaccine candidate.

Moderna’s coronavirus disease 2019 vaccine candidate, mRNA-1273, showed promise in interim data from its phase 1 study.

Investigators are looking for a new way to improve upon a 100-year-old vaccine.

Investigators are developing a new needle-less vaccine delivery method that would eliminate the need for refrigeration and could significantly reduce costs associated with immunizations.

Never before have so many brilliant minds, machines, and groups come together so quickly in an attempt to develop a vaccine.

The quadrivalent meningococcal vaccine is indicated persons 2 years of age and older in the United States.

Early treatment of shingles reduces symptoms and risk of serious complications.

Pharmacist reminders boost shingles vaccination compliance.

GlaxoSmithKline and Sanofi have prioritized public health over competition in their agreement, announced today.

“We know exactly where to fight this new virus,” University of Pittsburgh School of Medicine said.

The purpose of the project was to increase the number of influenza, pertussis, pneumococcal, and herpes zoster vaccines provided to adults.

Johnson & Johnson expects to initiate human clinical studies for its lead COVID-19 vaccine candidate by September 2020.

Health care providers should look out for more than just respiratory diagnoses in patients when it comes to influenza-associated complications, according to a recent study. 

A study identified significant similarities between SARS-CoV and SARS-CoV-2.

A new study identified demographics that characterize a higher risk of conscientious vaccination exemptions for children in Texas.

A clinical trial evaluating an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, has been launched, with volunteers receiving the first injection on March 16.

More than one-third of all children in the United States are not following the recommended vaccine schedule, according to a new study.

A new study examines why some individuals are able to fight off the flu better than others. The answer, in part, may lead back to childhood.

Vaccination is first line of defense.

British study supports exogenous boosting theory.

It’s never too far into flu season to educate patients.

A new method to produce vaccines could result in longer-lasting, cheaper vaccines and eliminate the need for refrigeration. 

Millennials were least likely to receive the flu vaccine and were the least-informed about the risks of influenza.